Commentary: Controversies in NICE guidance on chronic kidney disease

Commentary: Controversies in NICE guidance on chronic kidney disease

Show other versions (1)

Bibliographic Details
Main Authors:	Landray, M, Haynes, R
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Commentary: Controversies in NICE guidance on chronic kidney disease.
by: Landray, M, et al.
Published: (2008)

Commentary: Controversies in NICE guidance on antibiotic prescribing for self limiting respiratory tract infections in primary care.
by: Butler, C, et al.
Published: (2008)

Lipids in chronic kidney disease.
by: Lewis, D, et al.
Published: (2010)

Controversies in the Treatment of Abdominal Aortic Aneurysm (I): Is the NICE Guideline Nice to Patients?
by: Seung-Kee Min
Published: (2021-12-01)

Chronic heart failure in adults: summary of updated NICE guidance
by: Real, J, et al.
Published: (2018)

Commentary: NICE guidance on antibiotic prescribing for self limiting respiratory tract infections in primary care
by: Butler, C, et al.
Published: (2008)

Neprilysin inhibition in chronic kidney disease.
by: Judge, P, et al.
Published: (2014)

Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.
by: Armitage, J
Published: (2008)

Diagnosis and management of endometriosis: summary of NICE guidance
by: Kuznetsov, L, et al.
Published: (2017)

Endocarditis prevention: time for a review of NICE guidance
by: Martin Thornhill, et al.
Published: (2024-04-01)

Reduction in twin stillbirth following implementation of NICE guidance
by: Khalil, A, et al.
Published: (2020)

Management of hip fracture in adults: summary of NICE guidance.
by: Ftouh, S, et al.
Published: (2011)

NICE guidance in schizophrenia: How generalisable are drug trials?
by: Burns, T
Published: (2006)

Assessment and management of bipolar disorder: Summary of updated NICE guidance
by: Kendall, T, et al.
Published: (2014)

NICE guidance for off-pump CABG: turn off the pump.
by: Falk, V, et al.
Published: (2011)

Commentary on the burden of chronic kidney disease
by: Unadike B
Published: (2012-02-01)

Recognition, assessment and treatment of social anxiety disorder: summary of NICE guidance.
by: Pilling, S, et al.
Published: (2013)

Not really nice: a commentary on the recent version of NICE guidelines [NG193: chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain] by the Pain Net
by: Beatrice Korwisi, et al.
Published: (2021-11-01)

Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia.
by: Minhas, R, et al.
Published: (2009)

The controversy of klotho as a potential biomarker in chronic kidney disease
by: Li-Xia Yu, et al.
Published: (2022-09-01)

Modelling clinical narrative as computable knowledge: The NICE computable implementation guidance project
by: Philip Scott, et al.
Published: (2023-10-01)

Conventional and genetic evidence on the association between adiposity and chronic kidney disease
by: Zhu, P, et al.
Published: (2020)

Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance.
by: Visintin, C, et al.
Published: (2010)

Management of bacterial meningitis and meningococcal septicaemia in children and young people: Summary of NICE guidance
by: Visintin, C, et al.
Published: (2010)

Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance
by: Visintin, C, et al.
Published: (2010)

Which cardiovascular risk factors matter in chronic kidney disease?
by: Baigent, C, et al.
Published: (2007)

Blood pressure targets in patients with chronic kidney disease: Comments and controversies
by: Ying Zheng, et al.
Published: (2024-02-01)

Commentary: Controversies related to endogenous endophthalmitis
by: Naresh Babu, et al.
Published: (2020-01-01)

Venous thromboembolism management and the new NICE guidance: what the busy GP needs to know
by: Jones, N, et al.
Published: (2021)

Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease
by: Mihaylova, B, et al.
Published: (2019)

Dietary Guidance for Cardiovascular Health: Consensus and Controversies
by: Panagiota Pietri
Published: (2023-10-01)

Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial
by: Theodoros Eleftheriadis, et al.
Published: (2017-09-01)

Benefits of lowering cholesterol in chronic kidney disease Reply
by: Baigent, C, et al.
Published: (2011)

The National Institute for Health and Care Excellence (NICE) guidance on bladder cancer; a step in the right direction?
by: Trainor, S, et al.
Published: (2017)

Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis
by: Curtis, HJ, et al.
Published: (2018)

Benjamin Jowett's Pauline commentary: An atonement controversy
by: Atherstone, A
Published: (2003)

Omalizumab: NICE to USE you, to LOSE you NICE.
by: Bush, A, et al.
Published: (2013)

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease
by: Schlackow, I, et al.
Published: (2017)

(PREMIER POSTER - AWARD CANDIDATE) TREATMENT GUIDANCE IN WOMEN WITH WRIST FRACTURE: NICE TA161, NOGG AND FRAX
by: Weeks, C, et al.
Published: (2009)

NICE chronic heart failure update guideline 2018
by: Taylor, C, et al.
Published: (2019)